pembrolizumab
merck
['pembro', 'keynote-564', 'kidney cancer']
new data on adjuvant pembrolizumab after kidney cancer surgery presented by at #asco22. keynote-564 shows prolonged distant metastasis-free survival and clinically relevant time to subsequent anticancer therapy and 2nd disease progression.
cc: 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090